Kessler Foundation research scientist John DeLuca, PhD, has published a significant clinical article in Journal of Neurology, shedding light on the elusive nature of fatigue in multiple sclerosis (MS) and its implications for treatment.
German court denies validity of CureVac patent claim in fight with BioNTech over Covid-19 vaccine
A German court on Tuesday invalidated a CureVac patent that was part of the biotech’s ongoing fight with BioNTech over the mRNA technology used in